Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Anchorage. Study-provided care at no cost to qualified participants.
Access pancreatic cancer specialists in Anchorage at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the body (metastatic) and that have abnormal changes (alterations) in the fibroblast growth factor receptor (FGFR) gene. FGFR genes are genes that, when altered, can lead to and promote the growth of cancer i
Sponsor: Sameek Roychowdhury
Check if you qualify for this pancreatic cancer clinical trial in Anchorage, AK
If you're searching for pancreatic cancer treatment options in Anchorage, AK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anchorage research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.